profit from every €100 of sales.
Springer Nature AG & Co. KGaA
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2024.
You pay €66.39 for every €1 of profit it makes in a year.
of earnings would pay off all its debt.
Money in, money out
What Springer Nature AG & Co. KGaA sold, what it kept, and what it did with the cash.
Sales went from €1.85 billion in 2023 to €1.85 billion in 2024, with €68.3 million of profit last year.
Springer Nature AG & Co. KGaA vs. similar companies
Springer Nature AG & Co. KGaA grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Springer Nature AG & Co. KGaA | 66.4× · Very expensive | ||
Informa | 1,096.5× · Very expensive | ||
The New York Times | 33.8× · Expensive | ||
Pearson | 23.7× · Fair price | ||
Jiangsu Phoenix Publishing & Media | 13.1× · Cheap |
AI analysis
An AI analyst reads Springer Nature AG & Co. KGaA's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2023 | 2024 |
|---|---|---|
| 1,853 | 1,847 | |
| 1,593 | 1,610 | |
| 406 | 404 | |
| 665 | 612 | |
| 16 | 68 | |
| 0.08 | 0.34 | |
| 86.0% | 87.1% | |
| 21.9% | 21.9% | |
| 0.8% | 3.7% |
Balance sheet
| In millions of EUR | 2023 | 2024 |
|---|---|---|
| Total assets | 5,411 | 5,389 |
| Cash | 274 | 300 |
| Total debt | 3,643 | 1,893 |
| Total liabilities | 5,373 | 3,575 |
| 36 | 1,811 | |
| 190 | 199 | |
| 7.4% | 6.3% | |
| 43.7% | 3.8% |
Cash flow
| In millions of EUR | 2023 | 2024 |
|---|---|---|
| 492 | 531 | |
| 45 | 42 | |
| 447 | 490 | |
| Dividends paid | 0 | – |
| – | – | |
| – | – |
Valuation
- 66.4×
- –
- 0.20
- 2.2×
- 2.5×
- 9.3×
- 10.0×
- 10.8%
- 1.5%
- –
Profitability
- 87.1%
- 21.9%
- 3.7%
- –
- 10.1%
- 7.9%
- –
- –
- –
- –
Growth
- −0.3%
- +325.0%
- –
- –
- +2.3%
Financial health
- 1.6×
- 0.74
- –
- 4.9×
- 1.07
- –
- –
How it ranks in Communication Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Springer Nature AG & Co. KGaA
Is Springer Nature AG & Co. KGaA a good stock to buy?
A business with weak numbers, priced as if everything goes right. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Springer Nature AG & Co. KGaA AI analysis
What does Springer Nature AG & Co. KGaA do?
Springer Nature AG & Co. KGaA, together with its subsidiaries, engages in the publishing business in Germany, the United Kingdom, the United States, and internationally. The company operates through three segments: Research, Education, and Health. It is in Publishing, based in Berlin, Germany, with 9,479 employees.
Is Springer Nature AG & Co. KGaA stock halal?
No. Springer Nature AG & Co. KGaA does not pass our halal screen: its debt is 42% of its market value, at or above the 33% limit. How we check
Who are Springer Nature AG & Co. KGaA's competitors?
The largest listed companies in the same industry are Informa, The New York Times, Pearson and Jiangsu Phoenix Publishing & Media. The peers table on this page compares their profit, growth and price with Springer Nature AG & Co. KGaA's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.



